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OBJECTIVE—Insulin plays an important role in the hypotha-
lamic control of energy balance, especially by reducing food
intake. Emerging data point to a pivotal role of reactive oxygen
species (ROS) in energy homeostasis regulation, but their involve-
ment in the anorexigenic effect of insulin is unknown. Furthermore,
ROS signal derived from NADPH oxidase activation is required for
physiological insulin effects in peripheral cells. In this study, we
investigated the involvement of hypothalamic ROS and NADPH
oxidase in the feeding behavior regulation by insulin.
RESEARCH DESIGN AND METHODS—We ﬁrst measured
hypothalamic ROS levels and food intake after acute intracere-
broventricular injection of insulin. Second, effect of pretreatment
with a ROS scavenger or an NADPH oxidase inhibitor was
evaluated. Third, we examined the consequences of two nutri-
tional conditions of central insulin unresponsiveness (fasting or
short-term high-fat diet) on the ability of insulin to modify ROS
level and food intake.
RESULTS—In normal chow-fed mice, insulin inhibited food
intake. At the same dose, insulin rapidly and transiently in-
creased hypothalamic ROS levels by 36%. The pharmacological
suppression of this insulin-stimulated ROS elevation, either by
antioxidant or by an NADPH oxidase inhibitor, abolished the
anorexigenic effect of insulin. Finally, in fasted and short-term
high-fat diet–fed mice, insulin did not promote elevation of ROS
level and food intake inhibition, likely because of an increase in
hypothalamic diet-induced antioxidant defense systems.
CONCLUSIONS—A hypothalamic ROS increase through
NADPH oxidase is required for the anorexigenic effect of insulin.
Diabetes 58:1544–1549, 2009
T
he hypothalamus is a cerebral area involved in
the regulation of energy homeostasis. In this
context, insulin plays a pivotal role. By acting in
the hypothalamus, insulin reduces food intake
and body weight (1,2), activates sympathetic nerve out-
ﬂow to the brown adipose tissue (3), and suppresses
hepatic endogenous glucose production (4,5). In a situa-
tion of excess nutrient intake, the hypothalamus rapidly
becomes resistant to insulin before obesity and diabetes
onset (6,7). Moreover, inactivation of the neuronal insulin
receptor leads to the development of diet-induced obesity
with an increase in body fat, mild insulin resistance, and
elevated plasma insulin levels (8). Therefore, it is of prime
importance to elucidate cellular mechanisms by which
insulin acts on hypothalamic cells to understand central
early-onset diet-induced obesity and diabetes.
In recent years, emerging data point to a pivotal role of
reactive oxygen species (ROS) in the energy homeostasis
regulation by the hypothalamus. In response to an acute
overload of nutrients, a subtle rise of the ROS concentra-
tion within this area is sufﬁcient to reduce food intake (9)
or stimulate the parasympathetic nervous system as well
as pancreatic insulin secretion (10). Furthermore, the
gut-derived hormone ghrelin exerts its central effect on
feeding behavior by controlling hypothalamic ROS levels
(11). However, the role of ROS in the anorexigenic effect
of insulin and more generally in the brain insulin signaling
remains unknown. In peripheral insulin-sensitive cells,
ROS have been shown to control the crucial early steps in
insulin signaling (12–14). Moreover, they contribute to
propagation of the insulin cascade in these cells (15–17).
Thus, transient bursts of small amounts of ROS triggered
in response to insulin facilitate both the early and distal
insulin signaling pathway. Reinforcing this concept, it has
been recently shown that this transient insulin-induced
ROS production is also required in neuronal cells for the
enhancement of insulin receptor autophosphorylation, the
ﬁrst step in the insulin signaling pathway (18). These data
lead us to hypothesize that insulin might trigger ROS
elevation within the hypothalamus, which, in turn, would
inhibit food intake.
In peripheral cells, it is well established that both the
insulin-induced ROS rise and insulin cascade activation
are dependent on NADPH oxidase activity (12–17,19).
Blocking insulin-induced ROS production with an inhibitor
of NADPH oxidase activity (diphenyleneidonium) dramat-
ically reduces insulin signaling pathway activation and
thus its physiological effects (15).
Despite the demonstration of the crucial role of ROS
signaling and NADPH oxidase in peripheral insulin effects,
their involvement in brain insulin signaling has not yet
been investigated. Therefore, in this study we tested
whether the anorexigenic insulin effect required a ROS-
dependent signaling pathway within the hypothalamus.
For this purpose, we measured hypothalamic ROS levels
and food intake after intracerebroventricular insulin injec-
tion. The involvement of ROS and NADPH oxidase in
insulin-induced food intake inhibition was evaluated by
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inhibitor. Because central insulin responsiveness is known
to be altered by a short-term deﬁcit (20) as well as an
excess (7) of nutrient availability, we examined the con-
sequence of 18-h fasting or 3 days’ high-fat diet on insulin’s
ability to modify hypothalamic ROS levels and food intake.
RESEARCH DESIGN AND METHODS
All animal experiments were carried out in strict accordance with European
Communities Council Directive 86/609/EEC and the Guide for the Care and
Use of Laboratory Animals, edited by the National Research Council. For this
study, we used 7- to 8-week-old male C57BL6/J mice (Harlan Laboratories).
The animals were kept in a temperature-controlled room (22  1°C) on a 12-h
light/dark cycle with free access to food and water. Depending on the
experiment being conducted, mice were fed ad libitum with standard diet
(22.4% fat, 60.9% carbohydrate, and 16.7% protein, 2.9 kcal/g; R04T25; SAFE,
Augy, France) or high-fat diet (42.5% fat, 42.5% carbohydrate, and 15% protein,
4.4 kcal/g; customized; SAFE). For the fasting group, food was removed just
before dark onset (1900 h). For tissue collection, mice were killed by cervical
dislocation.
Surgery. Under anesthesia (0.4% isoﬂurane, 100% O2), mice underwent
stereotaxic surgery to implant a chronic stainless steel cannula (Charles
River). The third cerebral ventricle was targeted using the following coordi-
nates from bregma: anterior-posterior, –0.825 mm; dorsal-ventral, –5 mm; and
medial-lateral, 0 mm. The cannula was ﬁxed to the skull using dental cement.
Mice were ﬁnally housed individually and were allowed 1 week for recovery
before the experiment.
Drug administration. Injections into the third cerebral ventricle were
performed in awake mice. The injections (1 l) consisted of either 0.4 U
insulin (100 units/ml Actrapid recombinant human insulin; Novo Nordisk), 0.1
mmol/l Trolox (Calbiochem), 0.1 mmol/l diphenyleneiodonium (DPI; Sigma-
Aldrich), or vehicle. Insulin, Trolox, and DPI were prepared as stock solutions
in diluting medium for soluble insulin injection (Novo Nordisk), 1% ethanol,
and 1% DMSO, respectively. For injections, all drugs and their respective
vehicle were diluted in 0.9% NaCl. Injections were performed over 1 min. After
the infusion, the guide cannula was kept in place for an additional 30 s to allow
the drugs to diffuse away from the cannula tip.
Food intake measurement. Food was removed 1 h before intracerebroven-
tricular injection. Insulin was injected 4 h before dark onset (1500). Intrace-
rebroventricular injections of Trolox or DPI were performed 30 min prior to
the 0.4 U insulin injection. Just before the beginning of the dark period
(1900), food (10 g) was presented to the mice. Then, 12 and 24 h later, food
intake and body weight were measured.
Blood glucose measurement. Blood samples were collected from the tail 2 h
after 4 U insulin intracerebroventricular injection and used for measure-
ments of blood glucose. It was directly measured on a glucose analyzer
(Accu-Chek Active meter).
ROS detection. The dye 2,7-dichloroﬂuorescein diacetate (H2DCFDA;
Molecular Probes) was used to monitor intracellular change in H2O2 levels.
After intracerebroventricular injections, hypothalami were dissected and
immediately frozen in liquid nitrogen. After rapid thawing, tissues were
homogenized (20 strokes) with a Dounce homogenizer and a B-type pestle in
250 l of a ROS buffer (150 mmol/l KCl, 20 mmol/l Tris, 0.5 mmol/l EDTA, 1
mmol/l MgCl2, 5 mmol/l glucose, and 0.5 mmol/l octanoïc acid, pH 7.4).
Homogenates were exposed to 16 mol/l H2DCFDA and were incubated at
37°C for 30 min under agitation. Reaction was stopped with 125 lo f7 0 %
ethanol plus 125 l of 0.1 N HCl. Homogenates were then centrifuged at 3,000g
for 15 min at 4°C. Supernatants were collected, neutralized with 175 lo f1
mol/l NaHCO3, and centrifuged at 6,000g for 15 min at 4°C. As previously
described (9,10), ROS level was evaluated by measuring ﬂuorescence intensity
with a microplate reader (Victor; Wallac). Intensity of ﬂuorescence was
expressed as arbitrary units per microgram of proteins.
Reduced glutathione assay. Dissected hypothalami were immediately fro-
zen in liquid nitrogen. Tissues were homogenized (20 strokes) with a Dounce
homogenizer and a B-type pestle in a lysis saline solution (150 mmol/l KCl, and
3 mmol/l EDTA, pH 7.4). Homogenates (50 l) were mixed with 450 lo f5 %
metaphosphoric acid. Samples were then centrifuged at 1,500g for 10 min at
4°C. Supernatants were collected and used to detect reduced glutathione
(GSH). Glutathione assay was performed by reverse-phase high-performance
liquid chromatography as previously described (21). The results are expressed
as ﬁcomoles per microgram tissular protein.
Protein assay. Protein concentration of samples was determined using the
DC protein assay kit (Bio-Rad) according to the manufacturer’s instructions.
Statistical analysis. Data are the means  SE. Depending on the experiment
being conducted, data were compared by unpaired Student’s t test, the
Mann-Whitney U test, or one-way ANOVA. Differences among groups were
considered signiﬁcant at P  0.05.
RESULTS
Third-ventricle insulin injection decreases food
intake. To study the role of hypothalamic insulin signaling
in food intake regulation, we ﬁrst aimed to select the best
paradigm of acute insulin injection (Fig. 1A). We chose a
third-ventricle injection because acute insulin administra-
tion into the lateral ventricle was without effect on food
intake in mice (22). In comparison to vehicle-injected
animals, insulin signiﬁcantly reduced food intake 12 and
24 h after food presentation (Fig. 1B). This represented a
40% decrease in daily food intake. Concurrently to this
food intake inhibition, insulin also signiﬁcantly reduced
body weight at 12 and 24 h (Fig. 1C). To ensure that
intracerebroventricularly injected insulin did not indi-
rectly affect food intake through diffusion out of the brain,
we injected a higher dose of insulin and measured glyce-
mia. No change in plasma glucose was observed in this
condition, showing that the insulin effect on food intake
only depends on its effect on the brain (Fig. 1D).
Insulin induces a transient hypothalamic ROS
increase, which is required for food intake inhibition.
To determine whether insulin could induce ROS increase
in the hypothalamus, insulin was injected into the third
ventricle at a dose that inhibits food intake. Mice were
killed 5, 15, and 30 min later, and the ROS level was
evaluated using the ﬂuorescent redox-sensitive dye
H2DCFDA. Figure 2A shows that insulin induced a signif-
icant increase (36%) in the ROS level 15 min postinjec-
tion. This insulin-induced ROS increase was transient
because no modiﬁcation of ﬂuorescence intensity was
observed at either 5 or 30 min postinjection.
We then designed experiments to examine the physio-
logical relevance of this insulin-induced hypothalamic
ROS elevation. For this purpose, we assessed food intake
in response to acute intracerebroventricular insulin injec-
tion in combination with an intracerebroventricular pre-
treatment of Trolox, a ROS scavenger. We ﬁrst veriﬁed
that Trolox alone did not induce signiﬁcant change in
basal ROS levels and food intake, and then we investigated
the ability of Trolox to inhibit insulin-induced ROS pro-
duction. As illustrated in Fig. 2B, Trolox delivery 30 min
prior to insulin completely prevented insulin-stimulated
ROS increase. We then measured the effect of Trolox
pretreatment on food intake response. As for the ROS
level, intracerebroventricular Trolox injection completely
suppressed insulin-induced food intake inhibition without
signiﬁcantly modifying basal food intake (Fig. 2C). There-
fore, these results indicate that the transient insulin-
induced ROS elevation in the hypothalamus is required for
food intake inhibition.
NADPH oxidase is required for insulin-induced ROS
elevation and food intake inhibition. In peripheral
tissues, ROS produced by membrane-bound NADPH oxi-
dase are involved in the insulin signaling cascade. We
questioned whether, as in the periphery, NADPH oxi-
dase was involved in hypothalamic insulin ROS sig-
naling to regulate food intake. For this purpose, we
assessed food intake in response to acute intracerebro-
ventricular insulin injection in combination with prior
intracerebroventricular administration of DPI, a NADPH
oxidase inhibitor. To test the ability of DPI to inhibit the
ROS level increase, we ﬁrst measured the hypothalamic
ROS level 15 min after insulin injection with DPI pre-
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insulin-stimulated ROS elevation (Fig. 3A). In this con-
dition, DPI completely restored basal food intake in
insulin-injected mice (Fig. 3B). DPI treatment alone did
not signiﬁcantly modify basal ROS levels as well as food
intake. Therefore, these results indicate that NADPH
oxidase–dependent ROS increase within the hypothala-
mus is required for the central effect of insulin on food
intake inhibition.
Impairment of insulin-induced food intake inhibition
is associated with a lack of hypothalamic ROS level
increase. We then tested whether a modiﬁcation of insu-
lin effect on food intake was systematically associated
with a change of ROS level within the hypothalamus. For
this purpose, we chose two physiological situations that
produce central insulin unresponsiveness: 18-h fasting
(energy deﬁciency) (20) and 3 days’ high-fat diet (energy
excess) (7). Figure 4A shows that these two conditions
effectively suppressed insulin-induced food intake inhibi-
tion. According to our hypothesis, insulin did not promote
elevation of ROS level within the hypothalamus 15 min
after intracerebroventricular injection (Fig. 4B).
Because cellular ROS levels result from the balance
between their production and removal by various antioxi-
dants, we quantiﬁed hypothalamic glutathione, which is
considered as a major cellular ROS scavenging system
(23). Figure 4C shows that hypothalamic GSH levels were
increased by 18-h fasting (20%) and 3 days’ high-fat diet
(36%, P  0.05). Therefore, impairment of insulin-in-
duced inhibition of food intake was associated with a lack
of ROS increase in the hypothalamus, likely because of
higher GSH level. These results strengthen the crucial role
of hypothalamic ROS signaling in the anorexigenic effect
of insulin.
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FIG. 1. Acute insulin injection into the third ventricle reduces food intake at 12 and 24 h with no effect on plasma glucose. A: Schematic
representation of experimental procedures for food intake measurement. B: Mice were injected into the third ventricle with insulin (0.4 U) or
vehicle. Food intake was assessed by weighing residual chow 12 and 24 h after food presentation (n  9–10 mice per group). C: Body weight was
also measured at these time points (n  9–10 mice per group). D: Mice were injected into the third ventricle with a higher dose of insulin (4 U)
or vehicle. Plasma glucose was measured 2 h after injection (n  4 mice per group). Data are the means  SE. *P < 0.05, **P < 0.01 vs.
vehicle-injected group.
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FIG. 2. Insulin induces a transient hypothalamic ROS increase, which is required for food intake inhibition. A: Insulin effect on ROS production.
After intracerebroventricular injection of insulin (0.4 U) or vehicle, ROS levels were assessed by oxidation of H2DCFDA probe in the
hypothalamus at different times (n  5 mice per group). Dichloroﬂuorescein (DCF) ﬂuorescence is expressed in arbitrary units per microgram
of protein. B and C: Effect of Trolox on insulin-induced ROS production and food intake inhibition. Trolox (0.1 mmol/l) was intracerebroven-
tricularly injected 30 min before insulin (0.4 U). ROS levels were assessed in the hypothalamus 15 min after injections (n  5 mice per group)
(B). Food intake was assessed 12 h after food presentation (n  5–10 mice per group) (C). Data are the means  SE. *P < 0.05, **P < 0.01, ***P <
0.001 vs. vehicle- or insulin-injected group.
ROS-MEDIATED ANOREXIGENIC INSULIN EFFECT
1546 DIABETES, VOL. 58, JULY 2009DISCUSSION
In the current study, we describe the involvement of an
NADPH oxidase–dependent ROS signaling pathway in the
anorexigenic insulin effect. We demonstrate for the ﬁrst
time the physiological relevance of this concept in con-
scious mice.
Insulin was administrated into the third ventricle at a
dose (2.4 nmol/l) that is consistent with brain insulin
receptor afﬁnity (24,25) and that produces maximal food
intake inhibition in mice (2 and unpublished results). At
this physiological concentration, insulin induced a tran-
sient ROS level elevation within the hypothalamus (Fig. 2).
The current data demonstrate for the ﬁrst time in vivo that
insulin can effectively induce a change in ROS levels in the
central nervous system. Despite a relatively low magni-
tude (36%), this ROS level increase is similar to that
observed in the hypothalamus after glucose, lipid, or
ghrelin stimulation (9–11). These subtle ROS changes play
a key role in the control of the autonomous nervous
system and food intake. We show that this insulin-induced
ROS increase is required for food intake inhibition, thus
demonstrating its physiological relevance. First, the sup-
pression of insulin-stimulated ROS production using phar-
macological tools prevented insulin inhibition of food
intake. Second, in two nutritional conditions of central
insulin unresponsiveness (i.e., 18-h fasting or 3 days’
high-fat diet), impairment of the insulin effect on food
intake was associated with a lack of insulin-stimulated
ROS elevation within the hypothalamus. These data
strongly support the notion that cellular ROS constitute a
pivotal second messenger in hypothalamic signaling path-
ways involved in energy homeostasis regulation, espe-
cially by controlling nutrient sensing (9,10) and hormonal
signaling (11).
The involvement of an oxidant signal in the action of
insulin has been suggested for decades, mainly with the
observation that oxidants, including hydrogen peroxide,
mimic insulin’s effects on glucose transport and lipogene-
sis in adipose cells (26). A few years later, insulin itself
was shown to elicit the generation of hydrogen peroxide in
adipocytes (27). More recently, several elegant studies
carried out by Mahadev and colleagues (13–16) clearly
demonstrate that a physiological transient insulin-induced
ROS elevation mediates the increase of glucose uptake
through GLUT4 translocation to the plasma membrane in
adipocytes. Finally, creating mildly and transiently oxida-
tive intracellular conditions has been reported to enhance
insulin receptor activation, suggesting that optimal insulin
responsiveness involved a process of “redox priming” of
the -subunit (17,28). Our results reinforce these previous
data. Altogether, they strongly support the idea that a ROS
increase induced by insulin 1) forms an integral part of
insulin signaling pathway in the central nervous system as
in the periphery and 2) is relevant in whole-body energy
homeostasis.
The observed insulin-induced ROS increase peaks and
dissipates in a few minutes. Nevertheless, and in agree-
ment with the study by Brown et al. (2), feeding behavior
is signiﬁcantly inhibited for several hours after acute
intracerebroventricular insulin injection (Fig. 1). In adipo-
cytes, the early insulin-stimulated production of ROS is
required for insulin to elicit its late cellular responses,
especially by activating the insulin receptor substrate
(IRS)/phosphoinositide (PI)-3 kinase signaling pathway
(13–16,18,29). Within the hypothalamus, both insulin-in-
duced ROS and IRS/PI 3-kinase signaling pathways are
essential for the long-term inhibitory insulin effect on food
intake (Fig. 2) (30). Reciprocally, diet-induced impairment
of insulin effect on food intake is associated with an
alteration of these two insulin-activated signaling path-
ways (Fig. 4A and B) (7,31). The time course of insulin-
induced ROS level increase is similar to that observed for
insulin-induced PI 3-kinase activation in the hypothala-
mus, with activation a few minutes after stimulation,
persisting for 10–15 min, and gradually declining over
30–60 min (32). Altogether, these data strongly suggest
A B
0
50
100
150
200
D
C
F
 
f
l
u
o
r
e
s
c
e
n
c
e
r
e
l
a
t
i
v
e
 
t
o
 
v
e
h
i
c
l
e
s
 
(
%
)
*
**
Insulin
DPI
-
-
-
+
+
-
+
+
0
25
50
75
100
125
150
F
o
o
d
 
i
n
t
a
k
e
r
e
l
a
t
i
v
e
 
t
o
 
v
e
h
i
c
l
e
s
 
(
%
)
**
Insulin
DPI
-
-
-
+
+
-
+
+
**
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sured within the hypothalamus is a pivotal component of
insulin-induced IRS/PI 3-kinase signaling pathway activa-
tion, leading to a long-term decrease in food intake, likely
through modulation of the expression of genes such as
neuropeptide Y (33). Actually, hypothalamic neuropeptide
Y and pro-opio melanocortin C are well known to play a
key role in food intake regulation and to be down- or
upregulated by hormones such as leptin, ghrelin, or insulin
(2,11,33,34). Because insulin-induced PI 3-kinase activa-
tion occurs in these neuronal subpopulations (32), one can
speculate that the insulin-induced ROS increase occurs at
least in one of these, as has been recently demonstrated
for ghrelin (11).
That insulin induces a rapid and transient increase in
ROS level within the hypothalamus led us to investigate
the involvement of NADPH oxidase. Indeed, this enzyme
can be rapidly activated by insulin, leading to a rapid and
transient ROS increase in peripheral cells (14,15). In our
experimental conditions and similarly to Mahadev et al.
(15), pretreatment with a NADPH oxidase inhibitor (DPI)
completely abolished 1) the rapid and transient insulin-
induced ROS increase within the hypothalamus and 2) the
inhibitory insulin effect on food intake (Fig. 3). We can
thus conclude that NADPH oxidase plays a critical role in
the insulin signaling pathway in the brain as in the
periphery. There is now compelling evidence showing the
presence of NADPH oxidase homologues in rodent or
human brain tissue (35–38). Within the hypothalamus,
immunoreactivity for NADPH oxidase subunits, such as
p47
phox and gp91
phox, was found in arcuate, ventromedial,
and paraventricular nuclei, which are well known to be
involved in energy homeostasis regulation (36). More-
over, increasing data demonstrate the importance of
redox signaling derived from NADPH oxidase in normal
central nervous system processes, such as long-termpo-
tentiation and hippocampal-dependent memory or the
regulation of the cardiovascular system (38–42). Fur-
ther in vivo studies would permit us to conﬁrm that an
acute insulin-induced NADPH oxidase activation medi-
ates other hypothalamic insulin effects involved in en-
ergy homeostasis.
After fasting or short-term high-fat feeding, the brain
became less responsive to insulin, which resulted in a loss
of its effects on food intake (Fig. 4A) (7,20). In this context,
insulin-induced hypothalamic ROS elevation was sup-
pressed (Fig. 4B). To explain this result, we explored the
involvement of antioxidant defense systems. Indeed, the
rise in free fatty acid availability during fasting (because of
lipolysis) and short-term high-fat feeding (because of diet)
likely induced an increase in hypothalamic lipid oxidation
(9,11,43), a mechanism known to produce ROS (44). In the
physiological range, excess ROS is scavenged at the cel-
lular level by stimulating the synthesis of antioxidant
defense systems (44), as already demonstrated within the
hypothalamus of food-deprived animals (9,45). We re-
ported that hypothalamic GSH level is effectively higher
after high-fat feeding and to a lesser measure after fasting
(Fig. 4C), with a concomitant hypothalamic normal ROS
level. These data strongly suggest that 1) high-fat diet
induced excessive hypothalamic ROS production, which
had been well regulated by the cellular scavenging system,
and 2) this increased antioxidant defense system could
consequently overquench ROS produced under insulin
stimulation. Such a cellular mechanism has been already
proposed to explain the impaired peripheral insulin
sensitivity observed during physiological conditions
such as pregnancy (46). In animal models of long-term
high-fat diet–induced obesity (47,48) associated with
hypothalamic insulin resistance (47), oxidative stress
appears in the brain (48). This cellular stress has been
proposed to be a critical mechanism underlying devel-
opment of insulin resistance in obesity (49,50). We thus
hypothesized that 1) the early diet-induced central
insulin resistance is a consequence of an adaptive
mechanism to avoid cytotoxic ROS production, al-
though 2) in the long-term, the resistance might be
caused by an overwhelming of antioxidant defense
systems, and thus oxidative stress (44).
In conclusion, we report that insulin injected into the
third ventricle promoted a subtle and transient increase in
ROS level within the hypothalamus. This mechanism is
required for insulin food intake inhibition and involves
NADPH oxidase (Fig. 5). We thus suggest that 1)a n
NADPH oxidase–dependent ROS-sensitive signaling path-
way is implied in hypothalamic insulin action, and 2)
diet-induced impairment of hypothalamic ROS homeosta-
sis may contribute to cerebral insulin resistance.
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FIG. 5. Proposed mechanism of the involvement of a hypothalamic
NADPH oxidase–dependent ROS signaling pathway in the anorexigenic
effect of insulin. Insulin binds to its receptor leading to NADPH
oxidase activation and generation of ROS. This ultimately leads to
inhibition of food intake, likely though modulation of gene expression.
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